Inspire Medical Systems, Inc.INSPNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +24.52% | +22.75% | +10.82% | +10.49% | +12.25% |
| Gross Profit Growth | +23.88% | +22.52% | +9.86% | +12.84% | +14.37% |
| EBITDA Growth | +253.45% | +0.00% | -91.12% | -22.26% | -12.02% |
| Operating Income Growth | +242.95% | +0.00% | -165.03% | -32.64% | +44.62% |
| Net Income Growth | +138.60% | +0.00% | -136.68% | -46.30% | +286.36% |
| EPS Growth | +136.00% | +0.00% | -136.36% | -45.16% | +298.31% |
| EPS Diluted Growth | +134.69% | +0.00% | -137.50% | -43.33% | +305.22% |
| Weighted Average Shares Growth | +1.05% | +0.29% | -0.75% | -1.83% | -2.97% |
| Weighted Average Shares Diluted Growth | +1.70% | +2.35% | -2.96% | -3.37% | -4.99% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +300.65% | -175.65% | +0.00% | +31.07% | -24.16% |
| Free Cash Flow Growth | +573.10% | +0.00% | +0.00% | +31.19% | -32.73% |
| Receivables Growth | +3.54% | +28.06% | +72.72% | +20.33% | +28.61% |
| Inventory Growth | +136.44% | +103.63% | +106.07% | +110.25% | +81.35% |
| Asset Growth | +19.44% | +6.56% | +10.13% | +1.45% | +13.62% |
| Book Value per Share Growth | +19.21% | +7.61% | +7.03% | -2.54% | +16.73% |
| Debt Growth | +27.96% | +36.83% | +34.87% | +28.62% | +95.49% |
| R&D Expense Growth | -2.31% | -3.63% | -9.18% | -7.18% | -17.78% |
| SG&A Expenses Growth | +14.02% | +14.86% | +20.77% | +21.84% | +14.45% |